← back to search

Rasnik Singh

Henry Ford Health System · US
Area of research
Immunology · Dermatology
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Antifungal resistance and susceptibility, and Spondyloarthritis Studies and Treatments.
h-index
19
citations
4,164
works
52
NIH funding
primary concept
email

Recent publications

Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization
Microbiome 2018cited by 351position: middledoi
Systematic review of atopic dermatitis disease definition in studies using routinely collected health data
British Journal of Dermatology 2018cited by 59position: middledoi
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways
Scientific Reports 2018cited by 42position: middledoi
Influence of diet on the gut microbiome and implications for human health
Journal of Translational Medicine 2017cited by 2,566position: firstdoi
Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision
JAMA Dermatology 2017cited by 107position: middledoi
Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey
Dermatology and Therapy 2017cited by 99position: middledoi
The role of IL-17 in vitiligo: A review
Autoimmunity Reviews 2016cited by 145position: firstdoi
Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
Dermatology and Therapy 2016cited by 136position: middledoi
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
Psoriasis Targets and Therapy 2016cited by 129position: middledoi
The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation Injury
American Journal of Clinical Dermatology 2016cited by 73position: middledoi
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
Dermatology and Therapy 2016cited by 68position: middledoi
Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review
Journal of Dermatological Treatment 2016cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mio Nakamura · University of Michigan10 papers (2016–2018)Kristina Lee · Baptist Health South Florida8 papers (2016–2018)Benjamin Farahnik · University of Vermont8 papers (2016–2017)Michael Abrouk · Skin Cancer Foundation7 papers (2016–2017)Tian Hao Zhu · Albert Einstein College of Medicine7 papers (2016–2017)Tina Bhutani · University of California, San Francisco6 papers (2016–2017)Wilson Liao · University of California, San Francisco5 papers (2016–2018)John Koo · University of California, San Francisco5 papers (2016–2017)Derya Uçmak · Dicle University4 papers (2016–2018)Di Yan · Beijing University of Agriculture3 papers (2017–2018)Ladan Afifi · University of California, Los Angeles3 papers (2017–2018)Kristina M. Lee · Menlo School3 papers (2016–2017)Hsin-Wen Chang · Hsuan Chuang University3 papers (2017–2018)Maria L. Wei · University of California, San Francisco2 papers (2016–2017)Richard Ahn · The University of Texas Southwestern Medical Center2 papers (2017–2018)Mary‐Margaret Chren · Vanderbilt University Medical Center2 papers (2017–2018)Kourosh Beroukhim · Methodist Hospital2 papers (2016–2016)Xueyan Lu · Peking University1 papers (2018–2018)Douglas Fadrosh · University of California, San Francisco1 papers (2018–2018)Wilson Liao · University of California, San Francisco1 papers (2016–2016)